Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)

Name: Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)
Published: 2025
License: Public Domain

University of Florida · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

coronary-artery-disease

coronary arterial disease (cad), percutaneous coronary intervention (pci), coronary artery disease, dual antiplatelet therapy, high bleeding risk, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)

Related documents